Steve Kalloger

9PUBLICATIONS
23CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 18, 2026
Compartment-specific CD8 infiltration and disease-specific survival in resected ampullary adenocarcinoma.

|Jun 05, 2024
Cancer-related Fatigue and the Additive Effect of Treatment in the Context of Lymphoma: An Analysis of the Lymphoma Coalition's 2022 Global Patient Survey.

Steve E Kalloger, Amanda Watson, Shawn Sajkowski

|Sep 13, 2023
Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells.

Paalini Sathiyaseelan, Suganthi Chittaranjan, Steve E Kalloger

|Sep 30, 2022
Mapping the experiences of people with advanced cancer across multiple cancer types-a scoping review.

Steve E Kalloger, Cheryl Ho, Craig Mitton

|Oct 18, 2021
Advancing the Care of Pancreatic Cancer Patients: Moving Beyond Just Tumour Tissue.

Steve E Kalloger, Joanna M Karasinska, Cassia Warren

|Sep 21, 2020
Stroma vs epithelium-enhanced prognostics through histologic stratification in pancreatic ductal adenocarcinoma.

Steve E Kalloger, Joanna M Karasinska, Martin S Keung

Pageof 2

Frequent Collaborators

2 joint publications

Christine Chow

1 joint publications

Jing Xu

1 joint publications

Gregg B Morin

1 joint publications

Sharon M Gorski